Nanoparticles for accelerated drug development. Collaboration between global pharma and biotech to amplify the effectiveness of New Chemical Entities NCE
Location: Germany, Bavaria, Munich
Total raised: $20.51M
Founded date: 2011
Investors 4
| Date | Name | Website |
| - | BayBG | baybg.de |
| - | BayBG Vent... | baybg-vc.d... |
| - | Signet Hea... | signetheal... |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.07.2015 | Series A | $20.51M | - |
Mentions in press and media 9
| Date | Title | Description |
| 06.08.2024 | leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation | MUNICH, Aug. 06, 2024 (GLOBE NEWSWIRE) -- leon-nanodrugs GmbH (LEON), a pharmatech company specializing in the development of nanoencapsulation systems for genetic material and other active substances, announced today the closing of a Serie... |
| 26.10.2022 | Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing | LEON and Harro Höfliger to build and commercialize LEON’s NANOus, a novel aseptic manufacturing device to facilitate commercial production of LNP-encapsulated genetic materials and other APIs By enabling easy scale-up, PAT and GMP-complianc... |
| 16.04.2020 | leon-nanodrugs Completes Series B Funding Round | leon-nanodrugs GmbH, a Munich, Germany-based enabler of nano technology for the pharmaceutical industry, completed a Series B funding round of undisclosed amount. Backers included TVM Life Science Innovation I.L.P., CD-Venture GmbH, Albany ... |
| 09.01.2017 | leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer | leon nanodrugs GmbH appoints pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based company and its U.S. subsidiary leon-nanodrugs Inc, effective today. He succeeds Dr. Theron (Ted) Odlaug who will continue to serve the company ... |
| 09.01.2017 | leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer | leon nanodrugs GmbH appoints pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based company and its U.S. subsidiary leon-nanodrugs Inc, effective today. He succeeds Dr. Theron (Ted) Odlaug who will continue to serve the company ... |
| 17.08.2015 | Leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing | TVM Capital Life Science leads international syndicate of investors - an additional EUR 3 million investment is expected later in 2015 Munich, Germany, July 27, 2015 / B3C newswire / -- leon nanodrugs GmbH today announced that it completed... |
| 27.07.2015 | Daily funding roundup - July 27, 2015 | Palantir received $450M; DraftKings added $300M; Secret Escapes bagged $60M Buyatab Online Inc., a Vancouver, BC, Canada-based international provider of digital gift card solutions, completed a funding round of undisclosed amount. Backers w... |
| 27.07.2015 | leon nanodrugs Closes €18.5M Series A Funding | leon nanodrugs GmbH, a Munich, Germany-based nanotechnology-based drug development company, closed an €18.5m Series A funding. The round was led by TVM Capital Life Science, with participation from Signet Healthcare Partners (USA), LifeCare... |
| 27.07.2015 | leon-nanodrugs GmbH raises EUR 18.5 million in Series A financing | TVM Capital Life Science leads international syndicate of investors – an additional EUR 3 million investment is expected later in 2015 Munich, 27 July 2015 — leon nanodrugs GmbH today announced that it completed the first closing of its Se... |